Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Soft tissue augmentation using Restylane.

Brian Biesman1

  • 1Department of Otolaryngology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.

Facial Plastic Surgery : FPS
|January 12, 2005
PubMed
Summary

Restylane, a hyaluronic acid filler, is now FDA-approved for soft tissue augmentation in facial rejuvenation. This article introduces its proper use for enhancing facial aesthetics.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patient-Reported Outcomes After Treatment With OnabotulinumtoxinA for Platysma Prominence: Results From a Phase 2 Dose-Ranging Study.

Journal of cosmetic dermatology·2026
Same author

Monopolar Radiofrequency-Induced Fibroblast Stimulation for the Prevention and Improvement of Skin Laxity.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]·2025
Same author

Patient-Reported Outcomes for Glabellar Line Improvement and Satisfaction With the RelabotulinumtoxinA Ready-to-Use Liquid Formulation: Data From the Phase 3 READY-1 Trial.

Aesthetic surgery journal·2025
Same author

A Controlled Phase 2b Trial to Assess the Efficacy and Safety of a Single Intervention of OnabotulinumtoxinA for Treating Masseter Muscle Prominence.

Aesthetic surgery journal·2025
Same author

Improvement in Temple Hollowing with VYC-20L Hyaluronic Acid Filler: A Multicenter Randomized Controlled Trial of Safety and Effectiveness.

Plastic and reconstructive surgery·2025
Same author

Polynucleotides in Skin Regeneration: Targeting the Adenosine A2A Receptor and Salvage Pathway.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]·2024

Area of Science:

  • Dermatology
  • Aesthetic Medicine
  • Cosmetic Surgery

Background:

  • Soft tissue augmentation is crucial for facial rejuvenation.
  • Various materials have been employed for this purpose.
  • Hyaluronic acids are a recent advancement in aesthetic treatments.

Purpose of the Study:

  • To introduce Restylane, a novel hyaluronic acid dermal filler.
  • To provide guidance on the appropriate application of Restylane for soft tissue augmentation.
  • To inform healthcare professionals about the first FDA-approved hyaluronic acid product for facial rejuvenation.

Main Methods:

  • Review of hyaluronic acid technology and product development.
  • Clinical considerations for soft tissue augmentation with Restylane.
  • Techniques for administering Restylane for optimal aesthetic outcomes.

Main Results:

  • Restylane is the first hyaluronic acid filler approved by the FDA for soft tissue augmentation.
  • Proper usage techniques are essential for achieving desired facial rejuvenation results.
  • Hyaluronic acid fillers offer a new option for patients seeking non-surgical facial enhancement.

Conclusions:

  • Restylane provides a safe and effective option for soft tissue augmentation.
  • Understanding the proper use of Restylane is key to successful facial rejuvenation.
  • The introduction of Restylane marks a significant development in aesthetic medicine.

Related Experiment Videos